Food, Drugs, Healthcare, Life Sciences

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

Global Asbestos Awareness Week has just finished – a reminder that this problem still requires action within the construction industry.

In a recent LSIPR article published for World Health Day 2026, the spotlight is on the growing momentum in women’s health innovation, and the persistent gaps that still hamper progress.

The UK's Advertising Standards Authority has issued its first four rulings under new regulations restricting advertisements for "less healthy" food and drink products, offering crucial guidance on how these rules will be interpreted and enforced. These decisions reveal which promotional tactics pass muster and which cross the line, with implications for food brands, retailers, and influencers navigating the complex Nutrient Profiling Model requirements. The rulings demonstrate that while some food advertisi

The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.

Last year, consumer law was pushed to the very top of many businesses' compliance agenda and one area under regulatory scrutiny is use of online reviews.

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

Assays used in clinical trials vary widely in complexity and regulatory status.. They may be fully developed and marketed as in vitro diagnostic medical devices (IVDs), including companion diagnostics (CDx)...

The Court of Appeal has delivered a notable judgment on the interpretation of term and termination provisions in intellectual property licence agreements.